Live Breaking News & Updates on Nyse Ebs|Page 1

Stay updated with breaking news from Nyse ebs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Emergent BioSolutions (NYSE:EBS) Releases Quarterly Earnings Results, Beats Expectations By $4.24 EPS

Emergent BioSolutions (NYSE:EBS – Get Free Report) posted its quarterly earnings results on Wednesday. The biopharmaceutical company reported $0.59 earnings per share for the quarter, beating the consensus estimate of ($3.65) by $4.24, Zacks reports. Emergent BioSolutions had a negative net margin of 47.68% and a negative return on equity of 17.91%. The firm had […] ....

United States , Emergent Biosolutions Inc , Emergent Biosolutions Company Profile , Emergent Biosolutions , Get Free Report , Biosolutions Inc , Emergent Biosolutions Daily , Nyse Ebs ,

Emergent BioSolutions Releases New Survey Findings

Nearly 9 in 10 Americans surveyed agree opioid overdoses are a concern for teenagers and college students; parents in the survey want life-saving treatment. ....

United States , Richards Lindahl , Joe Papa , Assal Hellmer , Key Survey Findings , Bryter Inc , Emergent Biosolutions Inc , Us Department Of Education , Bryter Global , Nasal Spray , Opioid Crisis Among America , Urgent Need , White House Office , National Drug Control Policy , Regan Udall , Build Awareness , Apple Podcasts , Vice President , Nyse Ebs , Emergent Biosolutions ,

Traders Buy Large Volume of Put Options on Emergent BioSolutions (NYSE:EBS)

Emergent BioSolutions Inc. (NYSE:EBS – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Traders purchased 3,153 put options on the stock. This is an increase of 344% compared to the typical daily volume of 710 put options. Emergent BioSolutions Stock Performance Shares of NYSE:EBS traded up $0.03 on Wednesday, […] ....

United States , Emergent Biosolutions Inc , Emergent Biosolutions Company Profile , Tower Research Capital , Allspring Global Investments Holdings , Emergent Biosolutions , Get Free Report , Global Investments Holdings , Research Capital , Laurion Capital Management , Biosolutions Inc , Emergent Biosolutions Daily , Nyse Ebs ,

Emergent BioSolutions Reports First Quarter 2024 Financial

First Quarter 2024 Total Revenues of $300.4 million, above the prior guidance rangeFirst Quarter 2024 Net Income of $9.0 million and Adjusted EBITDA of. ....

United States , Joe Papa , Assal Hellmer , Josephc Papa , Company Canton , Us Department Of Defense , Company Camden , Development Expenses , Exchange Commission , Emergent Biosolutions Inc , First Quarter , Net Income , Diluted Share , Segment Gross Margin , Segment Adjusted Gross Margin , Anthrax Vaccine Adsorbed , Baltimore Bayview Manufacturing , Medical Countermeasure , Commercial Products , Bavarian Nordic , Nasal Spray , Commercial Product , Ended March , United States Securities , Adjusted Gross Margin , Adjusted Net Income ,

Emergent BioSolutions Announces Amendment to its Existing

GAITHERSBURG, Md., April 30, 2024 (GLOBE NEWSWIRE) Emergent BioSolutions Inc. (NYSE: EBS) announced that it has entered into a “Consent, Waiver and. ....

Richards Lindahl , Joe Papa , Assal Hellmer , Exchange Commission , Emergent Biosolutions Inc , Apple Podcasts , Private Securities Litigation Reform Act , Vice President , Nyse Ebs , Emergent Biosolutions ,